Yuzu extract prevents cognitive decline and impaired glucose homeostasis in β-amyloid-infused rats (Q38449976)

3 September 2017

Yuzu extract prevents cognitive decline and impaired glucose homeostasis in β-amyloid-infused rats (English)

1 reference

3 September 2017

Hye Jeong Yang

1

1 reference

3 September 2017

Jin Taek Hwang

2

1 reference

3 September 2017

Dae Young Kwon

3

1 reference

3 September 2017

Min Jung Kim

4

1 reference

3 September 2017

Suna Kang

5

1 reference

3 September 2017

Na Rang Moon

6

1 reference

3 September 2017

Sunmin Park

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

29 May 2013

1 reference

3 September 2017

1 reference

3 September 2017

143

1 reference

3 September 2017

7

1 reference

3 September 2017

1093-1099

1 reference

Body mass index in midlife and risk of Alzheimer disease and vascular dementia

3 September 2017

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Adult hippocampal neurogenesis and its role in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Insulin is a two-edged knife on the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Cyclic AMP response element-binding protein (CREB) phosphorylation: a mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Neuroprotective potential of phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Cytoprotective effects of hesperetin and hesperidin against amyloid β-induced impairment of glucose transport through downregulation of neuronal autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Anti-inflammatory effects of limonene from yuzu (Citrus junos Tanaka) essential oil on eosinophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Variation in major antioxidants and total antioxidant activity of Yuzu (Citrus junos Sieb ex Tanaka) during maturation and between cultivars

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Flavonoid permeability across an in situ model of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Alzheimer's disease 2012: the great amyloid gamble

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

The effects of acute and repeated oroxylin A treatments on Abeta(25-35)-induced memory impairment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Amyloid-β protein modulates insulin signaling in presynaptic terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

The molecular and cellular biology of tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Accelerated weight loss may precede diagnosis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

The relationship between difficulties in feeding oneself and loss of weight in nursing-home patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Forecasting the global burden of Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

Hesperetin ameliorates hyperglycemia induced retinal vasculopathy via anti-angiogenic effects in experimental diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

[14] Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.112.173401

21 January 2018

Identifiers

DOI

10.3945/JN.112.173401

1 reference

3 September 2017

1 reference